Publication:
REACT initiative: early cure of atherosclerosis through precision prevention.

Simple item page
dc.contributor.authorIbanez, Borja
dc.contributor.authorBundgaard, Henning
dc.date.accessioned2025-12-17T14:07:14Z
dc.date.available2025-12-17T14:07:14Z
dc.date.issued2025-09-02
dc.description.peerreviewedSí
dc.description.tableofcontentsREACT is funded by the Novo Nordisk Foundation and counts with the collaboration of companies providing in-kind contribution (Philips Healthcare, Zeiss, Bank of Santander). Other companies will be incorporated into the initiative through an in-kind contribution scheme. AI developments are funded through competitive grants from the Spanish Ministry of Digital Transformation and Public Function (NEXTGENERATION EU ‘AI-POCVUS-REACT’ and ‘ENPESA’). The initiative is designed, directed, and managed solely by the research team. Researchers have no conflicts of interest to declare related to the initiative.
dc.identifier.citationEur Heart J. 2025 Sep 2;46(33):3244-3246.
dc.identifier.journalEUROPEAN HEART JOURNAL
dc.identifier.pubmedID40746204
dc.identifier.urihttps://hdl.handle.net/20.500.12105/27076
dc.language.isoeng
dc.publisherOxford University Press
dc.relation.isreferencedbyPubMed
dc.relation.publisherversionhttps://doi.org/10.1093/eurheartj/ehaf179
dc.repisalud.institucionCNIC
dc.repisalud.orgCNICCNIC::Grupos de investigación::Laboratorio Traslacional para la Imagen y Terapia Cardiovascular
dc.rights.accessRightsopen access
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.titleREACT initiative: early cure of atherosclerosis through precision prevention.
dc.typeeditorial
dc.type.hasVersionVoR
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
REACT initiative_Eur Heart J_2025.pdf
Size:
1.76 MB
Format:
Adobe Portable Document Format
Download

Collections

Grupos de investigación